The "Golden Hours" Algorithm For the Management of the Multisystem Inflammatory Syndrome in Children (MIS-C).
COVID-19
IVIG
Kawasaki disease
algorithm
pediatric MIS-C
Journal
Global pediatric health
ISSN: 2333-794X
Titre abrégé: Glob Pediatr Health
Pays: United States
ID NLM: 101670224
Informations de publication
Date de publication:
2021
2021
Historique:
received:
14
08
2020
revised:
19
12
2020
accepted:
04
01
2021
entrez:
22
2
2021
pubmed:
23
2
2021
medline:
23
2
2021
Statut:
epublish
Résumé
The global concern of increasing number of children presenting with multisystem inflammatory syndrome in children (MIS-C) related to the coronavirus disease (COVID-19) has escalated the need for a case-oriented clinical approach that provides timely diagnosis and management. The aim of this study is to share our experience in managing 64 MIS-C patients of North African ethnicity guided by a risk-based algorithm. Sixty-four patients met the inclusion criteria, 19 (30%) patients were categorized as mild and moderate risk groups and cared for in an isolation ward and 45 patients who belonged to the high-risk group (70%) were admitted to the pediatric intensive care unit (PICU). Positive laboratory evidence of COVID-19 was found in 62 patients. Fever and dysfunction in 2 or more organs were confirmed in all cases (100%). Fifty patients (78%) presented with gastrointestinal symptoms, meanwhile only 10 patients (16%) had respiratory manifestations. Cardiac involvement was reported in 55 (86%) cases; hypotension and shock were found in 45 patients (70%) therein circulatory support and mechanical ventilations were needed for 45 and 13 patients respectively. Intravenous immunoglobulins (IVIG) were used for all cases and methylprednisolone was used in 60 patients (94%). Fifty-eight (91%) patients were discharged home after an average of 9 days of hospitalization. The mortality rate was 9% (6 patients).
Identifiants
pubmed: 33614843
doi: 10.1177/2333794X21990339
pii: 10.1177_2333794X21990339
pmc: PMC7868488
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2333794X21990339Informations de copyright
© The Author(s) 2021.
Déclaration de conflit d'intérêts
Declaration of Conflicting Interests: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Références
JAMA. 2020 Jul 21;324(3):259-269
pubmed: 32511692
JAMA Pediatr. 2020 Sep 1;174(9):868-873
pubmed: 32392288
Lancet. 2020 May 23;395(10237):1607-1608
pubmed: 32386565
J Infect. 2020 Jul;81(1):e24-e27
pubmed: 32283146
Circulation. 2017 Apr 25;135(17):e927-e999
pubmed: 28356445
Lancet. 2020 Jun 6;395(10239):1771-1778
pubmed: 32410760
J Biomed Sci. 2020 Jun 4;27(1):72
pubmed: 32498686
Intensive Care Med. 2017 Mar;43(3):304-377
pubmed: 28101605
Crit Care Med. 2017 Jun;45(6):1061-1093
pubmed: 28509730
Circulation. 2020 Aug 4;142(5):429-436
pubmed: 32418446
Pediatrics. 2020 Aug;146(2):
pubmed: 32439816
BMJ. 2020 Jun 3;369:m2094
pubmed: 32493739
N Engl J Med. 2020 Sep 3;383(10):994
pubmed: 32649078
Cell Host Microbe. 2020 Jul 8;28(1):117-123.e1
pubmed: 32411313
Eur J Pediatr. 2020 Jul;179(7):1079-1087
pubmed: 32474800
J Pediatr. 2020 Sep;224:24-29
pubmed: 32553861
JAMA. 2020 Jul 21;324(3):246-248
pubmed: 32511667
J Pediatric Infect Dis Soc. 2020 Jul 13;9(3):393-398
pubmed: 32463092
J Am Coll Surg. 2020 Aug;231(2):193-203.e1
pubmed: 32422349
Circulation. 2020 Jun 23;141(25):e933-e943
pubmed: 32270695
CJC Open. 2020 Nov;2(6):632-640
pubmed: 32935083
JAMA. 2020 Jul 21;324(3):294-296
pubmed: 32511676
Trends Cardiovasc Med. 2020 Oct;30(7):389-396
pubmed: 32702413